IPO
Aridis Pharmaceuticals, Inc.
We are a late-stage biopharmaceutical company focused on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.
Symbol
ARDS
Price Range
$13.00 - $15.00
Anticipated Date
TBD
Underwriters
Cantor, Maxim Group LLC, Northland Capital Markets
To view the prospectus for Aridis Pharmaceuticals, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277